Page last updated: 2024-08-24

iobitridol and Neuroendocrine Tumors

iobitridol has been researched along with Neuroendocrine Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Böning, G; Freyhardt, P; Kahn, JF; Kaul, D; Pavel, M; Rotzinger, R; Streitparth, F1
Beiderwellen, KJ; Bockisch, A; Buchbender, C; Hartung-Knemeyer, V; Kuehl, H; Lauenstein, TC; Poeppel, TD1

Other Studies

2 other study(ies) available for iobitridol and Neuroendocrine Tumors

ArticleYear
CT follow-up in patients with neuroendocrine tumors (NETs): combined radiation and contrast dose reduction.
    Acta radiologica (Stockholm, Sweden : 1987), 2018, Volume: 59, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Follow-Up Studies; Humans; Iohexol; Male; Middle Aged; Neuroendocrine Tumors; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Signal-To-Noise Ratio; Tomography, X-Ray Computed

2018
Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Investigative radiology, 2013, Volume: 48, Issue:5

    Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Gallium Radioisotopes; Gastrointestinal Neoplasms; Gastrointestinal Tract; Humans; Image Enhancement; Iohexol; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging

2013